Literature DB >> 16865295

Inhibitory effect of insulin on vasopressin-induced intracellular calcium response is blunted in hyperinsulinemic hypertensive patients: role of membrane fatty acid composition.

Koichi Maekawa1, Takeshi Tsujino, Komei Saito, Jong Il Kim, Yoshihiro Ikeda, Noriaki Emoto, Mitsuhiro Yokoyama.   

Abstract

Impaired insulin-mediated vasodilation has been implicated in hypertension that is associated with the metabolic syndrome. The aim of this study was to determine whether an abnormality in membrane fatty acid composition was related to a weakening of insulin's inhibitory effect on agonist-stimulated intracellular free calcium elevation. Mild to moderate hypertensive patients (n = 27) and normotensive controls (n = 11) were studied. Hypertensive patients were divided into normoinsulinemic patients (n = 14) and hyperinsulinemic patients (n = 13) according to the area under the curve of plasma insulin concentrations during a 75-g oral glucose tolerance test. Nonstimulated and arginine-vasopressin (AVP) (1 micromol/l)-stimulated intraplatelet free calcium concentrations (p[Ca(2+)](i)) were measured with or without insulin (100 microU/ml) preincubation. Platelet membrane fatty acid composition, intraerythrocyte sodium content, and the ouabain-sensitive sodium efflux rate constant (K (os)) of erythrocytes were also determined. Insulin preincubation reduced AVP-stimulated p[Ca(2+)](i) elevation in both normotensive controls and hypertensive patients. The inhibitory effect of insulin on AVP-stimulated elevation of p[Ca(2+)](i) (%Inhibition) was significantly (P < 0.05) blunted in hyperinsulinemic hypertensive patients (9.7% +/- 2.4%) as compared to normoinsulinemic hypertensive patients (17.4% +/- 2.7%) and normotensive controls (16.9% +/- 1.7%). In hypertensive patients, the %Inhibition was correlated negatively with saturated fatty acids (SFA) (r = -0.51, P < 0.05) and systolic blood pressure (r = -0.44, P < 0.05), and correlated positively with membrane polyunsaturated fatty acids (PUFA) (r = 0.53, P < 0.01) and K (os) (r = 0.53, P < 0.005). Multiple regression analysis showed that SFA, PUFA, and K (os) were the significant variables for %Inhibition. These findings indicate that an increase in SFA and a decrease in PUFA may cause insulin insensitivity in cellular calcium and sodium handling in hypertension with hyperinsulinemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16865295     DOI: 10.1007/s00380-005-0889-6

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   1.814


  45 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  Insulin release and peripheral sensitivity at the oral glucose tolerance test.

Authors:  J Cederholm; L Wibell
Journal:  Diabetes Res Clin Pract       Date:  1990-10       Impact factor: 5.602

Review 3.  The deadly quartet and the insulin resistance syndrome: an historical overview.

Authors:  N M Kaplan
Journal:  Hypertens Res       Date:  1996-06       Impact factor: 3.872

4.  Bezafibrate improves hypertension and insulin sensitivity in humans.

Authors:  Jong Il Kim; Takeshi Tsujino; Yoshio Fujioka; Komei Saito; Mitsuhiro Yokoyama
Journal:  Hypertens Res       Date:  2003-04       Impact factor: 3.872

5.  Insulin-mediated vasodilation: impairment with increased blood pressure and body mass.

Authors:  R D Feldman; G S Bierbrier
Journal:  Lancet       Date:  1993-09-18       Impact factor: 79.321

6.  Insulin reduces contraction and intracellular calcium concentration in vascular smooth muscle.

Authors:  A M Kahn; C L Seidel; J C Allen; R G O'Neil; H Shelat; T Song
Journal:  Hypertension       Date:  1993-11       Impact factor: 10.190

7.  The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids.

Authors:  M Borkman; L H Storlien; D A Pan; A B Jenkins; D J Chisholm; L V Campbell
Journal:  N Engl J Med       Date:  1993-01-28       Impact factor: 91.245

8.  Effect of alterations in membrane lipid unsaturation on the properties of the insulin receptor of Ehrlich ascites cells.

Authors:  B H Ginsberg; J Jabour; A A Spector
Journal:  Biochim Biophys Acta       Date:  1982-09-09

9.  Blunted inhibition by insulin of agonist-stimulated calcium, pH and aggregatory responses in platelets from hypertensive patients.

Authors:  R M Touyz; E L Schiffrin
Journal:  J Hypertens       Date:  1994-11       Impact factor: 4.844

10.  Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid.

Authors:  L H Storlien; A B Jenkins; D J Chisholm; W S Pascoe; S Khouri; E W Kraegen
Journal:  Diabetes       Date:  1991-02       Impact factor: 9.461

View more
  3 in total

1.  Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome.

Authors:  Giuseppe Derosa; Angela D'Angelo; Filippo Scalise; Maria A Avanzini; Carmine Tinelli; Emmanouil Peros; Elena Fogari; Arrigo F G Cicero
Journal:  Heart Vessels       Date:  2007-11-26       Impact factor: 2.037

2.  Plasma levels of copeptin in patients with coronary heart disease.

Authors:  San Bao Chai; Yong Ming Hui; Xue Min Li; Yang Xiao; Chao Shu Tang
Journal:  Heart Vessels       Date:  2009-04-01       Impact factor: 2.037

3.  Castration modifies aortic vasoreactivity and serum fatty acids in a sucrose-fed rat model of metabolic syndrome.

Authors:  Israel Perez; Mohammed El Hafidi; Karla Carvajal; Guadalupe Baños
Journal:  Heart Vessels       Date:  2009-04-01       Impact factor: 2.037

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.